Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

14 May 2026 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Darolutamide Tablets, 300 mg. The company has enclosed a press release in this regard. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1802.80
Dr. Reddys Labs. 1355.15
Cipla 1377.50
Lupin 2011.20
Zydus Lifesciences 1235.90
View more..